摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(difluoromethyl)-1,3-dimethyl-1H-pyrazole

中文名称
——
中文别名
——
英文名称
5-(difluoromethyl)-1,3-dimethyl-1H-pyrazole
英文别名
5-(Difluoromethyl)-1,3-dimethyl-1H-pyrazole;5-(difluoromethyl)-1,3-dimethylpyrazole
5-(difluoromethyl)-1,3-dimethyl-1H-pyrazole化学式
CAS
——
化学式
C6H8F2N2
mdl
——
分子量
146.14
InChiKey
NKJNIWNXFJOJDO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    2-甲氧基丙烯 、 、 甲基肼乙腈 为溶剂, 反应 2.0h, 生成 5-(difluoromethyl)-1,3-dimethyl-1H-pyrazole 、 3-(difluoromethyl)-1,5-dimethyl-1H-pyrazole
    参考文献:
    名称:
    In Situ Generated Fluorinated Iminium Salts for Difluoromethylation and Difluoroacetylation
    摘要:
    The use of TFEDMA, a fluoroalkyl amino reagent, for the difluoromethylation and difluoroacylation of arenes, heteroarenes, and C-H acidic compounds is reported. This approach allows for an efficient access to difluoromethylated products of high added value in good to excellent yields and with scale-up possibilities.
    DOI:
    10.1021/acs.orglett.5b02184
点击查看最新优质反应信息

文献信息

  • [EN] DOSAGE FORMS AND REGIMENS FOR AMINO ACID COMPOUNDS<br/>[FR] FORMES POSOLOGIQUES ET SCHÉMAS DE TRAITEMENT POUR DES COMPOSÉS D'ACIDES AMINÉS
    申请人:PLIANT THERAPEUTICS INC
    公开号:WO2020210404A1
    公开(公告)日:2020-10-15
    The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are ανβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP),
    该发明涉及用于每日给药的化合物(A)和化合物(I)的剂型:或其盐,其中R1、R2、R10、R11、R12、R13、R14、R15、R16、q和p如本文所述。化合物(A)、化合物(I)及其药物组成物是ανβ6整合素抑制剂,可用于治疗纤维化疾病,如特发性肺纤维化(IPF)和非特异性间质性肺炎(NSIP)。
  • MICROBIOCIDAL HETEROCYCLES
    申请人:Sulzer-Mosse Sarah
    公开号:US20140128406A1
    公开(公告)日:2014-05-08
    The present invention relates to heterocyclic compounds of formula I which have microbiocidal activity, in particular fungicidal activity as well as methods of using the compounds of formula (I) to control microbes: wherein A is x-C(R 10 R 11 )—C(═O)—, x-C(R 12 R 13 )—C(═S)—, x-O—C(═O)—, x-O—C(═S)—, x-N(R 14 )—C(═O)—, x-N(R 15 )—C(═S)—, x-C(R 16 R 17 )—SO 2 — or x-N═C(R 30 )—, in each case x indicates the bond that is connected to R 1 ; T is CR 18 or N; Y 1 , Y 2 , Y 3 , and Y 4 are independently CR 19 or N; Q is O or S; n is 1 or 2; p is 1 or 2, providing that when n is 2, p is 1. R 1 is (formula A) R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 , R 19 and R 30 each independently are hydrogen, halogen, cyano, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl; R 8 , R 14 and R 15 each independently are hydrogen or C 1 -C 4 alkyl; and R 9 is phenyl, benzyl or group (a), wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C 1 -C 4 alkyl, C 1 -C 4 haloalkyi, halogen, cyano, hydroxy and amino; or a salt or a N-oxide thereof.
  • US9301530B2
    申请人:——
    公开号:US9301530B2
    公开(公告)日:2016-04-05
查看更多